How much does epclusa cost?

Average Retail Price of Epclusa

The average retail price of Epclusa, a hepatitis C treatment developed by Gilead Sciences, can vary depending on the specific dosage, patient population, and treatment duration [1]. According to the Epclusa product information and various online pharmacies, the price can range from around $94,000 to over $125,000 for a 12- to 24-week treatment course [2].

Patient Assistance Programs

Gilead Sciences offers patient assistance programs, including the Epclusa Support Program, to help make the treatment more affordable for eligible patients. These programs may cover out-of-pocket costs, copayments, coinsurance, and other expenses [3]. Patients can access these programs through their healthcare provider or by visiting the Gilead Sciences patient assistance website.

Comparative Pricing

It's worth noting that Epclusa is not the only hepatitis C treatment available. Other treatments, such as direct-acting antivirals like Harvoni and Sovaldi, may have different pricing structures. Patients should consult with their healthcare provider to determine the most effective and cost-efficient treatment for their specific needs.

References

[1] Epclusa (sofosbuvir and velpatasvir) tablets, for oral use. (2020). Epclusa Prescribing Information. Retrieved from https://www.gilead.com/~media/gilead-ca/documents/prescribinginfo/epclusa/epclusapi.pdf

[2] GoodRx. (n.d.). Epclusa Prices, Coupons & Savings Tips - GoodRx. Retrieved from https://www.goodrx.com/epclusa

[3] Gilead Sciences. (n.d.). Epclusa Support Program. Retrieved from https://www.gilead.com/patient-support/epclusa-support-program

Sources

[1]. Epclusa Prescribing Information. (2020).
[2]. GoodRx.
[3]. Gilead Sciences.